International Journal of Pediatric Otorhinolaryngology
Review ArticleRisk factors for the development and severity of juvenile-onset recurrent respiratory papillomatosis: A systematic review
Introduction
Juvenile-onset recurrent respiratory papillomatosis (JoRRP) is a rare yet aggressive disease caused by the human papillomavirus (HPV). The wart-like growths in the upper airway are mostly due to HPV genotypes 6 and 11 [1], [2]. Several observational studies have associated the JoRRP to maternal vaginal condylomas [3], [4], [5], [6].
The incidence and prevalence of JoRRP vary from one country to another. The incidence has been estimated at 0.24–4.3 per 100,000 children, the prevalence at 1.11–2.59 per 100,000 children [7], [8], [9], [10]. Although the disease is rare, morbidity is notoriously high. Recurrent proliferative lesions in the respiratory tract can spread to the trachea, bronchi or pulmonary parenchyma and compromise local function such as vocalization, breathing and swallowing [11], [12], [13], [14], [15].
The course of the disease can vary from mild to severe. Some children experience minor symptoms with spontaneous and complete remission at puberty, while others require multiple surgeries throughout childhood [13] at great physical, emotional, and financial burden to the individual, the family, and society [16], [17]. In rare yet severe progression, the disease may transform into malignant lesions [14], or in 1–3% of cases, may spread to the lower respiratory tract, entailing high mortality [11].
Individual studies have analyzed the risk factors associated with the occurrence and severity of JoRRP but findings have not been consistently replicable. Various published reviews have described the clinical manifestations and treatment options [12], [16], [18], [19], [20], [21], [22], [23], [24], [25], [26]. None, however, has focused systematically on etiology and prognosis. This systematic review, by summarizing recently published data, seeks to provide an up-to-date understanding of the risk factors for acquisition and severity.
Section snippets
Search strategy
We conducted a comprehensive systematic review of studies investigating risk factors associated with the acquisition and severity of JoRRP. We searched EMBASE, MEDLINE and Evidence-Based Medicine Reviews (EBMR) databases using the OvidSP interface with the following combinations of keywords and Boolean operators: (Laryn$ OR respiratory) AND (HPV OR papilloma or Papillomaviridae OR Papillomavirus Infections) AND (Disease* OR lesion* OR infection*) OR (Juvenile onset recurrent papillomatosis OR
Description of included studies
Our initial search identified 1362 citations. Of these, we retrieved 102 unduplicated full-text articles that conformed to eligibility criteria (Fig. 1). We found 14 additional studies from the reference lists. We retained 32 studies altogether, of which three [30], [31], [32] focused on risk factors for both acquisition and severity of disease.
All 32 studies were observational and together reported on a total of 2287 JoRRP cases. Seven studies included both JoRRP and adult-onset recurrent
Discussion
JoRRP is a relatively rare disease. Prospective studies are therefore difficult to undertake. In this comprehensive systematic review, we found that most (24/32) of the studies on JoRRP were indeed retrospective, corresponding to a low-moderate level of evidence as determined by the Oxford Center for Evidence-based Medicine [28]. Some had limitations such that results had to be interpreted with caution: some simply described JoRRP cases without controls [49], [51]; others used a case–control
Conclusions
Many children are exposed to HPV, but few develop JoRRP. Maternal genital condylomas during pregnancy and delivery (vertical transmission) are the major risk factors for JoRRP acquisition, while the HPV-11 genotype and younger age at which a child develops JoRRP lesions are important determinants of severity and prognosis. Genetic and immunological profiles play a role in the incidence and aggressiveness of JoRRP. Most of the underlying factors for disease acquisition and clinical course are
Acknowledgements
The authors are grateful to Danielle Buch, medical writer/editor at the Applied Clinical Research Unit of the CHU Sainte-Justine Research Center, for critical revision and substantive editing of the manuscript. HT received a salary award from the Fonds de la recherche du Québec-Santé.
References (72)
- et al.
HPV types causing juvenile recurrent laryngeal papillomatosis in South Africa
Int. J. Pediatr. Otorhinolaryngol.
(2010) - et al.
Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis
Obstet. Gynecol.
(2003) - et al.
Lung involvement in juvenile onset recurrent respiratory papillomatosis: a systematic review of the literature
Int. J. Pediatr. Otorhinolaryngol.
(2008) - et al.
Recurrent respiratory papillomatosis
Otolaryngol. Clin. North Am.
(2012) - et al.
Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis
Hum. Immunol.
(2010) - et al.
HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis
Hum. Immunol.
(2004) - et al.
Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience
Otolaryngol. Head Neck Surg.
(2005) - et al.
Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation
Cancer Detect. Prev.
(2007) - et al.
Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR
Int. J. Pediatr. Otorhinolaryngol.
(2006) - et al.
Distribution and density of CD1a+ and CD83+ dendritic cells in HPV-associated laryngeal papillomas
Int. J. Pediatr. Otorhinolaryngol.
(2009)
Severity of juvenile onset recurrent respiratory papillomatosis is not associated with socioeconomic status in a setting of universal health care
Int. J. Pediatr. Otorhinolaryngol.
Children and partners of patients with recurrent respiratory papillomatosis have no evidence of the disease during long-term observation
Int. J. Pediatr. Otorhinolaryngol.
Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance
Clin. Immunol.
Role of cesarean section in prevention of recurrent respiratory papillomatosis – is there one?
Int. J. Pediatr. Otorhinolaryngol.
Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions
Gynecol. Oncol.
Possible transplacental transmission of human papillomaviruses
Am. J. Obstet. Gynecol.
Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx
Proc. Natl. Acad. Sci. U. S. A.
Risk factors for juvenile onset recurrent respiratory papillomatosis
Pediatr. Infect. Dis. J.
The relationship between juvenile laryngeal papillomatosis and maternal condylomata acuminata
J. Reprod. Med.
Human papillomaviruses: associations between laryngeal papillomas and genital warts
Pediatr. Infect. Dis. J.
The epidemiology of juvenile onset recurrent respiratory papillomatosis derived from a population level national database
Laryngoscope
Task force on recurrent respiratory papillomas. A preliminary report
Arch. Otolaryngol. Head Neck Surg.
Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle
Clin. Infect. Dis.
Juvenile laryngeal papillomatosis. An epidemiological study from the Copenhagen region
Acta Otolaryngol.
Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force
Arch. Otolaryngol. Head Neck Surg.
Recurrent respiratory papillomatosis
Clin. Otolaryngol. Allied Sci.
Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population
Laryngoscope
Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
Vaccine
National registry for juvenile-onset recurrent respiratory papillomatosis
Arch. Otolaryngol. Head Neck Surg.
Recurrent laryngeal papillomatosis. Retrospective analysis of 95 patients and review of the literature
Otolaryngol. Pol.
Recurrent respiratory papillomatosis
Obstet. Gynecol. Clin. North Am.
Recurrent respiratory papillomatosis
J. La. State Med. Soc.
Recurrent respiratory papillomatosis
Laryngoscope
Overview of recurrent respiratory papillomatosis
Curr. Opin. Otolaryngol. Head Neck Surg.
Recurrent respiratory papillomatosis
Arch. Dis. Child.
Recurrent respiratory papillomatosis: an overview of current thinking and treatment
Eur. Arch. Otorhinolaryngol.
Cited by (38)
Neonatal oropharyngeal infection by HPV in our area
2022, Anales de PediatriaGiant condyloma acuminatum in pregnancy
2022, Gynecologie Obstetrique Fertilite et SenologieHuman papillomavirus (HPV) in pregnancy – An update
2021, European Journal of Obstetrics and Gynecology and Reproductive BiologyPrevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil
2019, Auris Nasus LarynxCitation Excerpt :Clinically, two forms of RRP are recognized: juvenile onset RRP (JoRRP) and adult onset RRP (AoRRP), with 18 generally being the cut-off age for the JoRRP [5]. HPV transmission with RRP development at pediatric age is still unclear, but it is believed to occur vertically through the birth canal from a mother carrying genital condyloma during vaginal delivery [6]. However, the cesarean does not show a protective effect and the indication of this procedure only occurs in cases of bleeding or obstruction of the birth canal by the genital lesions.